Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03802006
Recruitment Status : Recruiting
First Posted : January 14, 2019
Last Update Posted : January 14, 2019
Sponsor:
Information provided by (Responsible Party):
Seoul National University Hospital

Brief Summary:
Investigators assess the gastric contents by ultrasonography in fasted patients with previous subtotal gastrectomy.

Condition or disease Intervention/treatment
Gastroparesis Diagnostic Test: Ultrasound assessment of gastric content

Detailed Description:
Investigators evaluate the gastric contents by ultrasonography in fasted patients with previous subtotal gastrectomy, quantitatively and qualitatively. The frequency of visualization fully will be also analyzed.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 24 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Ultrasound Assessment of Gastric Contents in Fasted Surgical Patients With Previous Subtotal Gastrectomy
Actual Study Start Date : November 15, 2018
Estimated Primary Completion Date : November 15, 2020
Estimated Study Completion Date : December 15, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
fasted patient with previous gastrectomy
The fasted patient with previous subtotal gastrectomy except exclusion criteria are included
Diagnostic Test: Ultrasound assessment of gastric content
Ultrasound assessment of gastric body is performed




Primary Outcome Measures :
  1. Incidence of full cross section image [ Time Frame: Before the induction of anesthesia ]
    The gastric remnant body is assessed by ultrasound and the incidence of cross sectional image visualized fully is evaluated


Secondary Outcome Measures :
  1. Type of gastric content assessed by gastric ultrasound [ Time Frame: Before the induction of anesthesia ]
    The type of gastric content is assessed by gastric ultrasound; solid, fluid, empty

  2. Cross section area of stomach body assessed by gastric ultrasound [ Time Frame: Before the induction of anesthesia ]
    Cross section area is assessed by gastric ultrasound in the supine and right lateral positions

  3. Incidence of full stomach [ Time Frame: Before the induction of anesthesia ]
    It is determined if the contents is solid or the amount of fluid is large.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
We will conduct a study targeting the patients with previous subtotal gastectomy among the patients fasted for an operation under general, spinal or MAC anesthesia, except people with other anatomical abnormality or mass of stomach except gastrectomy
Criteria

Inclusion Criteria:

  • The preoperative fasted patients with previous subtotal gastrectomy

Exclusion Criteria:

  • Other anatomical abnormality or mass of stomach except gastrectomy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03802006


Contacts
Layout table for location contacts
Contact: Tea Kyong Kim, M.D.,Ph. D. 82-2-870-2519 ktkktk@gmail.com

Locations
Layout table for location information
Korea, Republic of
Seoul National University Hospital Recruiting
Seoul, Korea, Republic of, 03080
Contact: Tae Kyong Kim, MD    82-2-2072-2467    ktkktk@gmail.com   
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Tea Kyong Kim, M.D.,Ph. D. Seoul National University Hospital

Layout table for additonal information
Responsible Party: Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT03802006     History of Changes
Other Study ID Numbers: L-2018-346
First Posted: January 14, 2019    Key Record Dates
Last Update Posted: January 14, 2019
Last Verified: October 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Gastroparesis
Stomach Diseases
Gastrointestinal Diseases
Digestive System Diseases
Paralysis
Neurologic Manifestations
Signs and Symptoms